Table 3.
Treatment Pattern for Patients with Chronic Hepatitis C Infection in South Korea
| Treatment pattern | No. (%) (n=1,191) |
|---|---|
| Treatment initiation | 541 (45.4) |
| Treatment regimen | |
| Conventional IFN+ribavirin | 3 (0.6) |
| PegIFN-α-2a or 2b | 18 (3.3) |
| PegIFN-α-2a or 2b+ribavirin | 509 (94.1) |
| Treatment schedule | |
| Standard* | 476 (88.0) |
| Shorten | 59 (10.9) |
| Extended | 6 (1.1) |
| Treatment withdrawal | 100 (18.5) |
| Reason for Tx withdrawal | |
| Adverse events | 66 (66.0) |
| No achievement of early virologic response | 15 (15.0) |
| Viral breakthrough | 1 (1.0) |
| F/U loss during Tx | 18 (18.0) |
IFN, interferon; pegIFN, pegylated IFN; Tx, treatment; F/U, follow-up.
*
Standard treatment was defined as 48 weeks for genotypes 1/4 and 24 weeks for genotypes 2/3/6.